MAP1LC3B and chronic myelogenous leukemia, BCR-ABL1 positive: Another study reported that de-methylation agent, 5-AZA, increased LC3B levels, autophagy activity, and cell apoptosis in human chronic myeloid leukaemia cell lines [37].